Clearline Capital »

Adaptive Biotechnologies Cor shares owned by Clearline Capital

Quarter-by-quarter ownership of Adaptive Biotechnologies Cor (ADPT) shares owned by Clearline Capital from 13F filings

Historical chart of Clearline Capital investment in Adaptive Biotechnologies Cor

Tip: Access up to 7 years of quarterly data

All positions including Adaptive Biotechnologies Cor held by Clearline Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptive Biotechnologies Cor by Clearline Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.1M 615k 5.12

More positions owned by Clearline Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Amazon (AMZN)
Perrigo SHS (PRGO)
Alight Com Cl A (ALIT)
Golar Lng SHS (GLNG)
NVIDIA Corporation (NVDA)
Alibaba Group Hldg Sponsored Ads (BABA)
Madison Square Grdn Sprt Cor Cl A (MSGS)
Tko Group Holdings Cl A (TKO)
Hewlett Packard Enterprise (HPE)
Etsy (ETSY)
Mediaalpha Cl A (MAX)
BioMarin Pharmaceutical (BMRN)
Endeavor Group Hldgs Cl A Com (EDR)
Masimo Corporation (MASI)

View all positions for Clearline Capital

Top funds holding Adaptive Biotechnologies Cor

Viking Global Investors
Rubric Capital Management
BlackRock
BlackRock
ARK Investment Management
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Aristotle Atlantic Partners
Massachusetts Financial Services
Geode Capital Management
State Street Corporation
Soleus Capital Management
Dimensional Fund Advisors
Pictet Asset Management Holding SA

View all funds holding Adaptive Biotechnologies Cor